Literature DB >> 34112130

Guidelines on analgosedation, monitoring, and recovery time for flexible bronchoscopy: a systematic review.

Daniel Strohleit1, Thomas Galetin2, Nils Kosse1, Alberto Lopez-Pastorini1, Erich Stoelben1.   

Abstract

BACKGROUND: Patients undergoing bronchoscopy in spontaneous breathing are prone to hypoxaemia and hypercapnia. Sedation, airway obstruction, and lung diseases impair respiration and gas exchange. The restitution of normal respiration takes place in the recovery room. Nonetheless, there is no evidence on the necessary observation time. We systematically reviewed current guidelines on bronchoscopy regarding sedation, monitoring and recovery.
METHODS: This review was registered at the PROSPERO database (CRD42020197476). MEDLINE and awmf.org were double-searched for official guidelines, recommendation or consensus statements on bronchoscopy from 2010 to 2020. The PICO-process focussed on adults (Patients), bronchoscopy with maintained spontaneous breathing (Interventions), and recommendations regarding the intra- and postprocedural monitoring and sedation (O). The guideline quality was graded. A catalogue of 54 questions was answered. Strength of recommendation and evidence levels were recorded for each recommendation.
RESULTS: Six guidelines on general bronchoscopy and three expert statements on special bronchoscopic procedures were identified. Four guidelines were evidence-based. Most guidelines recommend sedation to improve the patient's tolerance. Midazolam combined with an opioid is preferred. The standard monitoring consists of non-invasive blood pressure, and pulse oximetry, furthermore electrocardiogram in cardiac patients. Only one guideline discusses hypercapnia and capnometry, but without consensus. Two guidelines discuss a recovery time of two hours, but a recommendation was not given because of lack of evidence.
CONCLUSION: Evidence for most issues is low to moderate. Lung-diseased patients are not represented by current guidelines. Capnometry and recovery time lack evidence. More primary research in these fields is needed so that future guidelines may address these issues, too.

Entities:  

Keywords:  Bronchoscopy; Capnometry; Guideline; Hypercapnia; Monitoring; Patient safety; Recovery time

Year:  2021        PMID: 34112130     DOI: 10.1186/s12890-021-01532-4

Source DB:  PubMed          Journal:  BMC Pulm Med        ISSN: 1471-2466            Impact factor:   3.317


  43 in total

1.  AGREE II: advancing guideline development, reporting and evaluation in health care.

Authors:  Melissa C Brouwers; Michelle E Kho; George P Browman; Jako S Burgers; Francoise Cluzeau; Gene Feder; Béatrice Fervers; Ian D Graham; Jeremy Grimshaw; Steven E Hanna; Peter Littlejohns; Julie Makarski; Louise Zitzelsberger
Journal:  J Clin Epidemiol       Date:  2010-07-24       Impact factor: 6.437

Review 2.  Sedation in Bronchoscopy: A Review.

Authors:  Amanda J McCambridge; Richard Paul Boesch; John J Mullon
Journal:  Clin Chest Med       Date:  2017-12-13       Impact factor: 2.878

3.  Supplemental oxygen impairs detection of hypoventilation by pulse oximetry.

Authors:  Eugene S Fu; John B Downs; John W Schweiger; Rafael V Miguel; Robert A Smith
Journal:  Chest       Date:  2004-11       Impact factor: 9.410

4.  Randomized trial of endobronchial ultrasound-guided transbronchial needle aspiration under general anesthesia versus moderate sedation.

Authors:  Roberto F Casal; Donald R Lazarus; Kristine Kuhl; Graciela Nogueras-González; Sarah Perusich; Linda K Green; David E Ost; Mona Sarkiss; Carlos A Jimenez; Georgie A Eapen; Rodolfo C Morice; Lorraine Cornwell; Sheila Austria; Amir Sharafkanneh; Rolando E Rumbaut; Horiana Grosu; Farrah Kheradmand
Journal:  Am J Respir Crit Care Med       Date:  2015-04-01       Impact factor: 21.405

5.  Standardized Definitions of Bleeding After Transbronchial Lung Biopsy: A Delphi Consensus Statement From the Nashville Working Group.

Authors:  Erik E Folch; Amit K Mahajan; Catherine L Oberg; Fabien Maldonado; Eric Toloza; William S Krimsky; Scott Oh; Mark R Bowling; Sadia Benzaquen; Charles M Kinsey; Atul C Mehta; Sebastian Fernandez-Bussy; Javier Flandes; Kelvin Lau; Ganesh Krishna; Michael A Nead; Felix Herth; Alejandro A Aragaki-Nakahodo; Emanuela Barisione; Sandeep Bansal; Dragos Zanchi; Michael Zgoda; Peter O Lutz; Robert J Lentz; Christopher Parks; Mario Salio; Kenneth Perret; Colleen Keyes; Gregory P LeMense; John D Hinze; Adnan Majid; Merete Christensen; Jordan Kazakov; Gonzalo Labarca; Ernest Waller; Michael Studnicka; Catalina V Teba; Sandeep J Khandhar
Journal:  Chest       Date:  2020-02-14       Impact factor: 9.410

6.  Titrated sedation with propofol or midazolam for flexible bronchoscopy: a randomised trial.

Authors:  G Clark; M Licker; A B Younossian; P M Soccal; J-G Frey; T Rochat; J Diaper; P-O Bridevaux; J-M Tschopp
Journal:  Eur Respir J       Date:  2009-05-14       Impact factor: 16.671

7.  Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement.

Authors:  David Moher; Larissa Shamseer; Mike Clarke; Davina Ghersi; Alessandro Liberati; Mark Petticrew; Paul Shekelle; Lesley A Stewart
Journal:  Syst Rev       Date:  2015-01-01

8.  Flexible bronchoscopy with moderate sedation in COPD: a case-control study.

Authors:  Peter Grendelmeier; Michael Tamm; Kathleen Jahn; Eric Pflimlin; Daiana Stolz
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-01-04

9.  SEPAR and AEER consensus recommendations on the Use of Bronchoscopy and Airway Sampling in Patients with Suspected or Confirmed COVID-19 Infection.

Authors:  Rosa Cordovilla; Susana Álvarez; Liliana Llanos; Ana Nuñez Ares; Enrique Cases Viedma; David Díaz-Pérez; Javier Flandes
Journal:  Arch Bronconeumol       Date:  2020-03-31       Impact factor: 4.872

Review 10.  Safety and Efficacy of the Moderate Sedation During Flexible Bronchoscopic Procedure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Kyung Soo Hong; Eun Young Choi; Dong-Ah Park; Jinkyeong Park
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

View more
  1 in total

1.  The Efficacy and Safety of Remimazolam Tosilate Versus Dexmedetomidine in Outpatients Undergoing Flexible Bronchoscopy: A Prospective, Randomized, Blind, Non-Inferiority Trial.

Authors:  Xingfang Chen; Deqian Xin; Guangjun Xu; Jing Zhao; Qing Lv
Journal:  Front Pharmacol       Date:  2022-06-02       Impact factor: 5.988

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.